Highlights include: The race to develop long-acting, oral, and inhalable formulations Insights into AI-driven peptide design and transdermal delivery potential Analytical hurdles in characterizing complex synthetic peptides Perspectives from Novo Nordisk, Waters, Charles River, DFE Pharma, and more A look at novel indicationsfrom cardiovascular protection to alcohol use disorder and cognitive decline Whether youre driving GLP-1 innovation, optimizing delivery platforms, or evaluating market opportunities, this eBook delivers timely intelligence to inform your strategy
The communication of pro-inflammatory cytokines by mitochondrial ROS serves to reinforce the relationship between OS and inflammation (46)
Introduction The rapid adoption of GLP-1 weight-loss medications such as Ozempic, Wegovy, and Mounjaro is reshaping consumer eating behavior these drugs are increasingly used not only for diabetes management but also for appetite and weight control, influencing how people select, consume, and prioritize food
Lopez, Pedro, et al